Journal
EMBO REPORTS
Volume 7, Issue 11, Pages 1162-1167Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.embor.7400826
Keywords
amyotrophic lateral sclerosis; G86R mouse; neuromuscular junction; Nogo-A; skeletal muscle
Categories
Ask authors/readers for more resources
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by motor neuron loss and muscle wasting. In muscles of ALS patients, Nogo-A-a protein known to inhibit axon regeneration-is ectopically expressed at levels that correlate with the severity of the clinical symptoms. We now show that the genetic ablation of Nogo-A extends survival and reduces muscle denervation in a mouse model of ALS. In turn, overexpression of Nogo-A in wild-type muscle fibres leads to shrinkage of the postsynapse and retraction of the presynaptic motor ending. This suggests that the expression of Nogo-A occurring early in ALS skeletal muscle could cause repulsion and destabilization of the motor nerve terminals, and subsequent dying back of the axons and motor neurons.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available